Trailing-twelve-month (TTM) revenue is $587.61 Million with a year-over-year growth of (5.16%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $151,532,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $143,531,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-23 |
| Q1 FY2026Period ended 2026-03-31 | $135,595,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $156,953,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-29 |
| TTM revenue | $587,611,000 |
Current P/S: $121,704,833 market capitalization ÷ $587,611,000 TTM revenue = 0.21x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:24:30.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $156.95M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:25:41.562Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Arcadia Segment | N/A | N/A | $300M | $299M | $250M | N/A |
| DynaEnergetics Segment | $146M | $175M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| NobelClad Segment | $83M | $85M | $90M | $105M | $105M | $93M |
$587.61M
$587.61 Million
(5.16%)
vs. $619.58M a year ago (TTM)
+20.27%
5 Year compound annual growth rate
1 Year
(5.16%)
3 Year
(6.66%)
5 Year
+20.27%
10 Year
+13.67%
15 Year
+7.98%
20 Year
+9.46%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $609.84M | ($33.01M) | (5.14%) |
| 2024 | $642.85M | ($76.34M) | (10.61%) |
| 2023 | $719.19M | +$65.10M | +9.95% |
| 2022 | $654.09M | +$393.97M | +151.46% |
| 2021 | $260.12M | +$30.95M | +13.51% |
| 2020 |
TTM Growth
(5.16%)
3-Year CAGR
(6.66%)
5-Year CAGR
+20.27%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:25:41.562Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $315M |
| $288M |
| $270M |
| NobelClad Segment | $83M | $85M | $90M | $105M | $105M | $93M |
|---|
| $229.16M |
| ($168.39M) |
| (42.36%) |
| 2019 | $397.55M | +$71.12M | +21.79% |
| 2018 | $326.43M | +$133.63M | +69.31% |
| 2017 | $192.80M | +$34.23M | +21.58% |
| 2016 | $158.57M | ($8.34M) | (5.00%) |
